Overall, TTF-1-diffuse/Napsin A-negative (or weak) profile should raise a consideration of NEC (small cell or large cell) since most adenocarcinomas with robust TTF-1 expression are also strongly positive for Napsin A, but this is not invariable. This evidence concerns the gene TTF1 and neuroendocrine carcinoma.